SCTX today
$15.37-$0.99 (-6.05%)close Nov 16, 2026Trend
DailyDowntrend (starting)
4 hourDescending Triangle
1 hourStrong Bearish
15 minSymmetric Triangle
5 minStrong Bearish
Daily trend turns up above $35.40
Key levels
Resistance$22.07
Resistance$18.30
Support$15.29
Nasdaq · Healthcare
Scribe Therapeutics, Inc. (SCTX)
What Is the Price Target for SCTX?
SEPT Low Target
$37.00
SEPT Mid Target
$60.00
SEPT High Target
$60.00
Analyst Consensus
$60.00
Is SCTX a Buy or Sell Right Now?
Thesis
Test your own strategy on SCTX
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on SCTX with SEPT’s own market data.
Start Free Trial →Is SCTX Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$60.00
0
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with SCTX?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →SCTX Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for SCTX
PREVIEWRecent off-exchange (dark pool) prints for SCTX: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:37:05 | $15.61 | 1,167 | $$18K | MIDPOINT |
| 20:05:04 | $16.06 | 1,001 | $$16K | SELL |
| 18:32:44 | $16.47 | 3,000 | $$49K | BUY |
| 18:32:31 | $16.34 | 2,910 | $$48K | SELL |
| 18:32:31 | $16.18 | 10,500 | $$170K | SELL |
5 dark pool trades shown · $$301K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Scribe Therapeutics, Inc. (SCTX) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →SCTX — frequently asked questions
What is SCTX stock price today?
Scribe Therapeutics, Inc. (SCTX) is at $15.37, down 6.05% (-$0.99) at the Nov 16, 2026 close.
Why is SCTX stock moving today?
Latest SCTX news — Sep 3, 2026: HC Wainwright & Co. kept its Buy rating on SCTX.
Why did SCTX stock move on Nov 12, 2026?
Scribe Therapeutics reported a quarterly loss of $0.68 per share, which was smaller than analysts expected, though revenue of $1.600M fell short of forecasts. The company also filed a Form 8-K disclosing a major company event.
What is the SCTX price target?
The average analyst price target for SCTX is $60.00, ranging from $37 to $60, based on 6 analysts.
What do analysts rate SCTX?
Analyst ratings for SCTX: 0 Buy, 6 Hold, 0 Sell — consensus Hold.
Did SCTX beat earnings?
SCTX last reported on Sep 2, 2026: EPS -$2.62 vs -$3.62 expected — a beat of 27.6%.
What are SCTX support and resistance levels?
Support: $15.29. Resistance: $18.30, $22.07, $27.20.
What are insiders doing with SCTX?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on SCTX?
Sep 3, 2026: HC Wainwright & Co. kept its Buy rating on SCTX.